Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Utidelone plus Bevacizumab for Advanced Breast Cancer with Brain Metastases
NCT05357417Phase 2Unknown
- Sponsor
- Henan Cancer Hospital
- Start
- Apr 2022
- Primary completion
- May 2024
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of utidelone in breast cancer, sponsored by Henan Cancer Hospital. Status: unknown.
02
Drugs
utidelone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05357417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05357417.